Impact of reduction of susceptibility to SARS-CoV-2 on epidemic dynamics in four early-seeded metropolitan regions
Abstract As we enter a chronic phase of the SARS-CoV-2 pandemic, with uncontrolled infection rates in many places, relative regional susceptibilities are a critical unknown for policy planning. Tests for SARS-CoV-2 infection or antibodies are indicative but unreliable measures of exposure. Here inst...
Guardado en:
Autores principales: | Thomas J. Barrett, Karen C. Patterson, Timothy M. James, Peter Krüger |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/39946f8e7c634315b5e381bb76fa6f12 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Molecular benchmarks of a SARS-CoV-2 epidemic
por: Hakon Jonsson, et al.
Publicado: (2021) -
The epidemicity index of recurrent SARS-CoV-2 infections
por: Lorenzo Mari, et al.
Publicado: (2021) -
Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands
por: Ed Slot, et al.
Publicado: (2020) -
Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area
por: S. Wesley Long, et al.
Publicado: (2020) -
Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic
por: Laith J. Abu-Raddad, et al.
Publicado: (2021)